Effects of Tirofiban in Patients with Acute Myocardial Infarction and Diabetes Mellitus undergoing Primary Percutaneous Coronary Intervention
CONCLUSION: The administration of tirofiban before reperfusion therapy compared with after reperfusion therapy is more effective in reducing the hyperthrombotic load, thrombus aspiration, inflammatory factors, and cTNI and can effectively improve myocardial perfusion and heart function.PMID:37855337 | DOI:10.2174/0115701611251882231012080210
Source: Current Vascular Pharmacology - Category: Drugs & Pharmacology Authors: Xiuying Tang Runjun Li Source Type: research
More News: Angioplasty | Bleeding | Cardiology | Cardiovascular | Coronary Angioplasty | Diabetes | Diabetes Mellitus | Drugs & Pharmacology | Endocrinology | Heart | Heart Attack | Percutaneous Coronary Intervention | Perfusion | Study | Thrombosis